Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer: A Comprehensive Analysis of 26,957 Patients with NSCLC

Tomoya Kawaguchi(NHO Kinki Chuo Chest Medical Center), Minoru Takada(NHO Kinki Chuo Chest Medical Center), Akihito Kubo(NHO Kinki Chuo Chest Medical Center), Akihide Matsumura(NHO Kinki Chuo Chest Medical Center), Shimao Fukai(Ibarakihigashi National Hospital), Atsuhisa Tamura(New Tokyo Hospital), Ryusei Saito(Kuma Hospital), Yosihito Maruyama(Osaka Prefecture University), Masaaki Kawahara(NHO Kinki Chuo Chest Medical Center), Sai‐Hong Ignatius Ou(University of California, Irvine)

Journal of Thoracic Oncology

March 30, 2010

10.1097/jto.0b013e3181d2dcd9

Cited by 359

Abstract

Related Papers

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

Tony Mok, Yi‐Long Wu, Sumitra Thongprasert et al.|New England Journal of Medicine|2009|8.2k

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

Peter Goldstraw, John Crowley, Kari Chansky et al.|Journal of Thoracic Oncology|2007|3.7k

The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung Cancer

Pieter E. Postmus, Élisabeth Brambilla, Kari Chansky et al.|Journal of Thoracic Oncology|2007|1.6k

Lung cancer in never smokers — a different disease

Sophie Sun, Joan H. Schiller, Adi F. Gazdar|Nature reviews. Cancer|2007|1.6k

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

Kathy S. Albain, John J. Crowley, Michael LeBlanc et al.|Journal of Clinical Oncology|1991|736